Inventurus Knowledge Solutions Earnings Call Transcript: Key Takeaways
IKS Health delivered strong 21% YoY revenue growth, yet the TrueBridge acquisition lowers margins to the 26-27% range temporarily.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
IKS Health delivered strong 21% YoY revenue growth, yet the TrueBridge acquisition lowers margins to the 26-27% range temporarily.
IKS Health delivered strong Q1 FY27 results with Revenue of INR 8,936 mn and EBITDA margin of 33%. Strategy focuses on AI integration and expansion in US healthcare markets.
IKS Health reported strong Q4 FY26 performance with 18.5% revenue growth (INR 857 cr). Strategy focuses on AI-native 'Platform Systems of Action' and integrating the TruBridge acquisition.
IKS Health delivered a strong FY26 with 20% revenue growth and significant margin expansion, though reported PAT was aided by one-time forex gains.
Inventurus Knowledge Solutions (IKS Health) reported strong FY26 performance with 20% INR revenue growth and significant margin expansion (EBITDA 34%, PAT 23%). The firm is transitioning to an AI-native healthcare enablement platform.
IKS Health announced a $557M acquisition of TruBridge to dominate the U.S. rural healthcare market. Strategic shift from 'System of Action' to an integrated 'System of Record' model.